디티앤씨 187220

http://comp.fnguide.com/SVO2/asp/SVD_Main.asp?pGB=1&gicode=A187220&cID=&MenuYn=Y&ReportGB=&NewMenuID=101&stkGb=701 

디티앤씨(A187220) | Snapshot | 기업정보 | Company Guide

- 120억원 규모 사모 CB발행 결정 속약세 4,870원(-6.53%)  - 2023.07.10
 ▷지난 7일 장 마감 후 채무상환자금 확보 목적으로 케이비증권 주식회사 신탁 등 대상 
  120.00억원 규모의 사모 전환사채권 발행 결정
  (전환가액:5,540원, 전환청구일:2024-07-11 ~ 2028-06-11) 공시. 
- 투자포인트 : 바이오 기술서비스에서 연구단계부터 상품화단계까지 모든 서비스를 제공하여 
  수익성 향상 및 수주 증가 Not Rated 주가 (10/16, 원) 9,690 -   한국투자 - 2018.10.18
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=497059
- 5G, 바이오로 영역 확장 Not Rated  현재주가 10,950 원 - 이베스트증권 - 2018.09.21 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=494177
- 5G와 바이오 성장 모멘텀 긍정적 Not Rated 현재가 (9/13 원) 11,200 -KB증권 - 2018.09.14 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=493336
- 철도 관련 시험검증 자회사 등 성장을 위한 초석 다지기목표주가 (원) NA 
  현재가 (5/ 30 , 원) 13,000 - KB증권 - 2018.05.31
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=479583
- 대기만성 (大器晩成 ) 목표주가 Not Rated 현재가 (5/15) 11,400원 - IBK투자 - 2018.05.16 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=477745
- 실적개선 본격화 Not Rated 주가(18/04/13) 14,150 원 -SK증권 - 2018.04.16
  http://hkconsen sus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=472706
- 실적개선 본격화, 시험인증에서 CRO, 금융업까지 Not Rated - SK증권 - 2018.04.12 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=472282